학술논문
Safety and immunogenicity of the rVSV∆G-ZEBOV-GP Ebola virus vaccine candidate in healthy adults: a phase 1b randomised, multicentre, double-blind, placebo-controlled, dose-response study
Document Type
Article
Author
Heppner, DG; Kemp, TL; Martin, BK; Ramsey, WJ; Nichols, R; Dasen, EJ; Fusco, J; Crowell, J; Link, C; Creager, J; Monath, TP; Das, R; Xu, ZJ; Klein, R; Nowak, T; Gerstenberger, E; Bliss, R; Sheldon, EA; Feldman, RA; Essink, Brandon J; Smith, WB; Chu, L; Seger, WM; Saleh, J; Borders, JL; Adams, M; Heppner, D Gray, Jr; Kemp, Tracy L; Martin, Brian K; Ramsey, William J; Nichols, Richard; Dasen, Emily J; Link, Charles J; Das, Rituparna; Xu, Zhi Jin; Sheldon, Eric A; Nowak, Teresa A; Monath, Thomas P
Source
In The Lancet Infectious Diseases August 2017 17(8):854-866
Subject
Language
ISSN
1473-3099